Transaction in Own Shares

Summary by AI BETAClose X

Melrose Industries PLC has announced the purchase of 24,400 ordinary shares between June 29, 2026, and July 2, 2026, through Merrill Lynch International. The volume-weighted average purchase price ranged from 463.0410p to 490.2150p per share. These acquired shares will be held in treasury, bringing the total number of shares held in treasury to 65,261,226, with 1,246,214,095 ordinary shares remaining in issue excluding treasury shares.

Disclaimer*

Melrose Industries PLC
06 July 2026
 







6ᵗʰ July 2026




Melrose Industries PLC

("Melrose" or the "Company")

Transaction in Own Shares

 






The Company announces today it has purchased the following number of its ordinary shares of £0.001 each through Merrill Lynch International ("MLI") in the period from 29ᵗʰ June 2026 to 2nd July 2026.







Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (pence)

Highest price per share (p)

29 June 2026

XLON

463.0410

6,100

460.5000

467.3000

30 June 2026

XLON

475.3549

6,100

465.4000

480.0000

1 July 2026

XLON

478.0123

6,100

473.9000

485.1000

2 July 2026

XLON

490.2150

6,100

472.2000

494.4000













The Company intends to hold the purchased shares in treasury.







Following the above transaction, the Company has 65,261,226 ordinary shares in treasury and has 1,246,214,095 ordinary shares in issue (excluding treasury shares).













Individual Transactions

 



In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by the MLI on behalf of the Company as part of the buyback programme is attached to this announcement.

http://www.rns-pdf.londonstockexchange.com/rns/0509L_1-2026-7-3.pdf








For further information please contact:




Warren Fernandez                        Company Secretary



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings